Most Recent Articles about MRK
Merck's Ebola Vaccine Approved for Use in Four African Countries https://www.fool.com/investing/2020/02/14/mercks-ebola-vaccine-approved-for-use-in-four-afri.aspx?source=iedfolrf0000001 Feb 14, 2020 - The World Health Organization is calling it a milestone in Ebola prevention.
Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails http://www.zacks.com/stock/news/765605/pharma-stock-roundup-abbv-agn-post-q4-results-another-alzheimers-study-fails?cid=CS-ZC-FT-analyst_blog|stock_roundup-765605 Feb 14, 2020 - AbbVie (ABBV) and Allergan (AGN) announce Q4 results.
Bristol-Myers' (BMY) CAR T Cell Therapy Gets Priority Review http://www.zacks.com/stock/news/765593/bristol-myers-bmy-car-t-cell-therapy-gets-priority-review?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-765593 Feb 14, 2020 - Bristol-Myers' (BMY) BLA for lisocabtagene maraleucel gets Priority Review from the FDA.

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals